生物社会决定因素反映了长期存在的癌症差异
David P Turner1, Robert A Winn2, Victoria J Findlay1
1Department of Surgery, Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, VA, USA.
Trends in cancer
|June 5, 2024
概括
健康的生物社会决定因素受到社会,环境和生物因素的影响,为癌症差异提供了洞察力. 这些分子因素是生活经验和生物学之间的桥梁,有助于跨学科研究.
科学领域:
- 公共卫生 公共卫生
- 遗传学 是一个遗传学.
- 社会学 社会学 社会学
背景情况:
- 社会,环境和生物因素对健康结果产生重大影响.
- "健康的生物社会决定因素"的概念整合了各种风险因素.
- 了解这些决定因素对于解决健康差距至关重要.
研究的目的:
- 引入和定义"健康的生物社会决定因素".
- 探索生物社会决定因素在癌症差异中的作用.
- 突出跨学科方法的重要性.
主要方法:
- 文献审查和概念综合.
- 对有关风险因素和健康结果的现有数据的分析.
- 生物社会决定因素的框架开发.
主要成果:
- 生物社会决定因素代表经验和生物学交集的分子因素.
- 这些决定因素有助于解释癌症差异的复杂性.
- 跨学科研究可以利用生物社会决定因素获得更深入的见解.
结论:
- 健康的生物社会决定因素是了解复杂的健康问题,如癌症差异的关键.
- 综合社会,环境和生物因素是必不可少的.
- 未来的研究应该专注于生物社会决定因素的分子机制.
相关概念视频
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Cancer Survival Analysis
343
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K


